Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis

Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people i...

Full description

Bibliographic Details
Main Authors: O. S. Mikhaylova, A. V. Krikova
Format: Article
Language:Russian
Published: IRBIS LLC 2022-07-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/693